ViperaTAb®, is a Polyvalent Immune Fab (Ovine) antivenom, comprising specific antibody fragments that bind and neutralise Vipera berus venom components, including proteases, lipases and cardiotoxins, facilitating their redistribution away from target tissues and subsequent elimination from the body.  ViperaTAb is currently available on a named patient basis in Europe under a distribution agreement with Flynn Pharma Limited.  

For all product enquiries please contact Flynn Pharma.  For telephone enquiries, please see the following link https://www.flynnpharma.com/viperatab-contact-numbers; for written enquiries please see the following link https://www.flynnpharma.com/contact-us.